Homeward homepage

Homeward, Rite Aid team-up to support seniors in rural areas

Rite Aid pharmacists will be able to introduce Medicare-eligible customers to Homeward's clinical services, including annual wellness visits, screenings, and risk assessments.

mPharma taps TytoCare to bring telehealth to pharmacies in Africa

The two companies have already seen success in improving healthcare access in remote communities throughout Ghana, Kenya, Uganda, Zambia, and Nigeria.
FundamentalVR - Endovascular

FundamentalVR expands into the endovascular space

The company also offers CollaborationVR, a virtual space designed for healthcare professionals to accelerate procedural and product adoption together.

Northwell Health and Aegis Ventures launch Ascertain, a healthcare AI company creation platform

The platform brings $100 million in seed-stage funding and permanent long-term growth capital to systematically launch healthcare AI companies at scale.
Cipher Health

CipherHealth unveils CipherConnect, a conversational patient engagement solution

The company also launched a suite of pre-care digital front door solutions powered by CipherConnect to drive appointment volume and reduce no-shows.
Carbon Health app

Carbon Health launches a diabetes program that integrates continuous at-home and in-person care

The provider brings its omnichannel healthcare approach to chronic condition management and sets the standard for the future of primary care.
Brightline website

Brightline launches virtual coaching program for young children with autism

The Getting an Early Start on Autism Program builds on top of current support models and fills gaps in care by delivering virtual training to caregivers.
reSET digital therapeutic

Pear Therapeutics to offer its digital therapeutics through telehealth partners

The company's first telehealth offering is with PursueCare to offer patients an end-to-end virtual continuum of comprehensive addiction recovery care.
Rock Health Q1 2022 graph

Rock: Q1 2022 U.S. digital health funding hits $6.0B across 183 deals

Supply chain and energy disruptions, market corrections, and the Russian invasion of Ukraine are new variables entering public and venture funding equations.
Pear Therapeutics homepage

Pear Therapeutics ended 2021 with $4.2M in revenue, expects $22M this year

Yes, the digital therapeutics market is taking off...

Get the most important digital health news delivered straight to your inbox, every Monday. Subscribe to our FREE newsletter!